Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Enanta Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4051265A1 | Application | FUNKTIONALISIERTE PEPTIDE ALS ANTIVIRALE MITTEL | A61K38/00; A61P31/14; C07D401/14; C07D403/12; C07D403/14; C07D405/14; C07K5/0202; C07K5/06139; C07K5/06165; C07K5/0823 | September 07, 2022 |
| WO2022182861A1 | Application | ANTIVIRAL HETEROCYCLIC COMPOUNDS | September 01, 2022 | |
| AR122280A1 | Application | COMPUESTOS HETEROCÍCLICOS ANTIVIRALES | August 31, 2022 | |
| US11420976B2 | Grant | Heterocyclic compounds as anti-viral agents | A61K45/06; C07D491/048 | August 23, 2022 |
| EP4037688A1 | Application | ANTIVIRALE HETEROCYCLISCHE VERBINDUNGEN | A61K31/4375; A61K31/443; A61K31/4709; A61K31/496; A61K31/497; A61K31/501; A61K31/502; A61K31/506; A61K31/519; A61K31/53; A61K31/538; A61K45/06; A61P31/12; C07D471/04; C07D491/048; C07D519/00 | August 10, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer